The E-cadherin gene (CDH1) variants T340A and L599V in gastric and colorectal cancer patients in Korea

Gut

Volumn 47, Issue 2, 2000, Pages 262-267

  Kim, H C ^a   Wheeler, J M D ^a   Kim, J C ^b   Ilyas, M ^a   Beck, N E ^a   Kim, B S ^b   Park, K C ^b   Bodmer, W F ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

CDH1; Colorectal cancer; E cadherin; Family history; Gastric cancer; Missense variant

Indexed keywords

UVOMORULIN;

ADENOMATOUS POLYP; ARTICLE; CANCER RISK; COLORECTAL CANCER; CONTROLLED STUDY; GENE MUTATION; GENOTYPE; HUMAN; KOREA; MAJOR CLINICAL STUDY; ONSET AGE; PRIORITY JOURNAL; STOMACH CANCER;

ADOLESCENT; ADULT; AGED; CADHERINS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COLORECTAL NEOPLASMS; FEMALE; GENOTYPE; GERM-LINE MUTATION; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MUTATION, MISSENSE; NEOPLASM PROTEINS; PEDIGREE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; SEQUENCE ANALYSIS, DNA; STOMACH NEOPLASMS;

EID: 0033931066     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.47.2.262     Document Type: Article

References (43)

1. Houlston RS, Collins A, Slack J, Morton NE. Dominant genes for colorectal cancer are not rare. Ann Hum Genet 1992;56:99-103.
2. Guilford P, Hopkins J, Harraway J, et al. E-cadherin germline mutations in familial gastric cancer. Nature 1998; 392:402-5.
3. Gayther SA, Gorringe KL, Ramus SJ, et al. Identification of germ-line E-cadherin mutations in gastric cancer families of European origin. Cancer Res 1998;58:4086-9.
4. Berx G, Becker KF, Hofler H, van Roy F. Mutations of the human E-cadherin (CDH1) gene). Hum Mutat 1998;12: 226-37.
5. Efstathiou JA, Liu D, Wheeler JMD, et al. Mutated E-cadherin (CDH1) is associated with increased tumorigenicity, loss of adhesion and of responsiveness to the motogenic trefoil factor 2 in colon carcinoma cells. Proc Natl Acad Sci USA 1999;96:2316-21.
6. Takeichi M. Cadherin cell adhesion receptor as a morphogenetic regulator. Science 1991;251:1451-5.
7. Gumbiner B. Cell adhesion: The molecular basis of tissue architecture and morphogenesis. Cell 1996;84:345-57.
8. Berx G, Staes K, van Hengel J, et al. Cloning and characterization of the human invasion suppressor gene E-cadherin (CDH1). Genomics 1995;26:281-9.
9. Overduin M, Harvey TS, Bagby S, et al. Solution structure of the epithelial cadherin domain responsible for selective cell adhesion. Science 1995;267:386-9.
10. Nagafuchi A, Takeichi M. Cell binding function of E-cadherin is regulated by the cytoplasmic domain. EMBO J 1988;7:3679-84.
11. Gumbiner BM, McCrea PD. Catenins as mediators of the cytoplasmic functions of cadherins. J Cell Sci Suppl 1993;17:155-8.
12. c39 associated with E-cadherin complexes. Mol Cell Biol 1994;14:8333-42.
13. Nigam AK, Savage FJ, Boulos PB, Stamp GW, Liu D, Pignatelli M. Loss of cell-cell and cell-matrix adhesion molecules in colorectal cancer. Br J Cancer 1993;68:507-14.
14. Kinsella AR, Lepts GC, Hill CL, Jones M. Reduced E-cadherin expression correlates with increased invasiveness in colorectal carcinoma cell lines. Clin Exp Metastasis 1994;12:335-42.
15. Matsuura K, Kawanish J, Fujii S, et al. Altered expression of E-cadherin in gastric cancer tissues and carcinomatous fluid. Br J Cancer 1992;66:1122-30.
16. Berx G, Cleton-Jansen AM, Nollet F, et al. E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J 1995;14:6107-15.
17. Risinger JI, Berchuck A, Kohler MF, Boyd J. Mutation of the E-cadherin gene in human gynecologic cancers. Nat Genet 1994;7:98-102.
18. Becker KF, Atkinson MJ, Reich U, et al. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 1994;54:3845-52.
19. Oda T, Kanai Y, Oyama T, et al. E-cadherin gene mutations in human gastric carcinoma cell lines. Proc Natl Acad Sci USA 1994;91:1858-62.
20. Berx G, Cleton-Jansen A, Strumane K, et al. E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene 1996;13:1919-25.
21. Becker KF, Höfler H. Frequent somatic allelic inactivation of the E-cadherin gene in gastric carcinomas. J Natl Cancer Inst 1995;87:1082-4.
22. Tamura G, Sakata K, Nishizuka S, et al. Inactivation of the E-cadherin gene in primary gastric carcinomas and gastric carcinoma cell lines. Jpn J Cancer Res 1996;87:1153-9.
23. Muta H, Noguchi M, Kanai Y, Ochiai A, Nawata H, Hirohashi S. E-cadherin gene mutations in signet ring cell carcinoma of the stomach. Jpn J Cancer Res 1996;87: 843-8.
24. Hiraguri S, Godfrey T, Nakamura H, et al. Mechanisms of inactivation of E-cadherin in breast cancer cell lines. Cancer Res 1998;58:1972-7.
25. Berx G, Nollet F, Strumane K, von Roy F. An efficient and reliable multiplex PCR-SSCP mutation analysis test applied to the human E-cadherin gene. Hum Mutat 1997;9:567-74.
26. Morton RA, Ewing CM, Nagafuchi A, Tsukita S, Isaacs WB. Reduction of E-cadherin levels and deletion of the α-catenin gene in human prostate cancer cells. Cancer Res 1993;53:3585-90.
27. Oyama T, Kanai Y, Ochiai A, et al. A truncated β-catenin disrupts the interaction between E-cadherin and α-catenin: A cause of loss of intercellular adhesiveness in human cancer cell lines. Cancer Res 1994;54:6282-7.
28. Graff JR, Herman JG, Lapidus RG, et al. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res 1995;55: 5195-9.
29. Yoshiura K, Kanai Y, Ochiai A, Shimoyama Y, Sugimura T, Hirohashi S. Silencing of the E-cadherin invasion- suppressor gene by CpG methylation in human carcinomas. Proc Natl Acad Sci USA 1995;92:7416-19.
30. Shibata T, Gotoh M, Ochiai A, Hirohashi S. Association of plakoglobin with APC a tumor suppressor gene product, and its regulation by tyrosin phosphorylation. Biochem Biophys Res Commun 1994;203:519-22.
31. Graff JR, Greenberg VE, Herman JG, et al. Distinct patterns of E-cadherin CpG island methylation in papillary, follicular, Hurthle's cell, and poorly differentiated human thyroid carcinoma. Cancer Res 1998;58:2063-6.
32. Perl A, Wilgenbus P, Dahl U, Semb H, Christofori G. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 1998;392:190-3.
33. Frayling IM, Beck NE, Ilyas M, et al. The APC variants I1307K and E1317Q are associated with colorectal tumors, but not always with a family history. Proc Natl Acad Sci USA 1998;95:10722-7.
34. Vasen HF, Mecklin JP, Khan PM, Lynch HT. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 1991;34:424-5.
35. Rodriguez-Bigas MA, Boland CR, Hamilton SR, et al. A National Cancer Institute workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst 1997;89: 1758-62.
36. Vasen HF, Wijnen JT, Menko FH, et al. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 1996;110:1020-7.
37. Laken SJ, Petersen GM, Gruber SB, et al. Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nat Genet 1997;17:79-83.
38. Woodage T, King SM, Wacholder S, et al. The APC I1307K allele and cancer risk in a community-based study of Ashkenazi Jews. Nat Genet 1998;20:62-5.
39. Wheelock MJ, Buck CA, Bechtol KB, Damsky CH. Soluble 80-kd fragment of cell-CAM 120/80 disrupts cell-cell adhesion. J Cell Biochem 1987;34:187-202.
40. Kintner C. Regulation of embryonic cell adhesion by the cadherin cytoplasmic domain. Cell 1992;69:225-36.
41. 2+ binding site of uvomorulin abolish the adhesive function. Cell 1990;63:1033-8.
42. Richards FM, McKee SA, Rajpar MH, et al. Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer. Hum Mol Genet 1999; 8:607-10.
43. McKinlay Gardner RJ, Macrae FA, Hopkins J. E-cadherin unlikely to be a common "low penetrance" gene for colorectal cancer. Am J Hum Genet 1999;84:169-71.